Abstract
Micelle-associated epoetin is still a possible explanation for the upsurge of pure red blood cell aplasia associated with subcutaneous use of epoetin alpha in patients with chronic renal failure.
References
A. P. Villalobos S. R. Gunturi G. A. Heavner (2005) ArticleTitleInteraction of polysorbate 80 with erythropoietin: a case study in protein–surfactant interactions Pharm. Res. 22 1186–1194 Occurrence Handle10.1007/s11095-005-5356-7 Occurrence Handle1:CAS:528:DC%2BD2MXmt1yntLk%3D Occurrence Handle16028020
S. Hermeling H. Schellekens D. J. A. Crommelin W. Jiskoot (2003) ArticleTitleMicelle-associated protein in epoetin formulations: A risk factor for immunogenicity? Pharm. Res. 20 1903–1907 Occurrence Handle10.1023/B:PHAM.0000008034.61317.02 Occurrence Handle1:CAS:528:DC%2BD3sXpvVShsL0%3D Occurrence Handle14725351
B. Sharma F. Bader T. Templeman P. Lisi M. Ryan G. A. Heavner (2004) ArticleTitleTechnical investigations into the cause of the increased incidence of antibody-mediated pure-red cell aplasia associated with Eprex® Eur. J. Hosp. Pharm. 5 86–91
S. Hermeling, L. Aranha, J. M. A. Damen, M. Slijper, H. Schellekens, D. J. A. Crommelin, and W. Jiskoot. Structural characterization and immunogenicity in wildtype and immune tolerant mice of degraded recombinant human interferon alpha2b. Pharm. Res. 22:1997–2006 (2005).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hermeling, S., Jiskoot, W., Crommelin, D.J.A. et al. Reaction to the paper: Interaction of Polysorbate 80 with Erythropoietin: A Case Study in Protein–Surfactant Interactions. Pharm Res 23, 641–642 (2006). https://doi.org/10.1007/s11095-006-9573-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11095-006-9573-5